Egypt’s Senate Approves Sovereign Sukuk Law

A general view of empty streets in downtown Cairo, amid the coronavirus disease (COVID-19) outbreak, during the traditional spring holiday of 'Shem al-Neseem', in Cairo, Egypt, May 3, 2021. REUTERS/Sayed Sheasha/File Photo
A general view of empty streets in downtown Cairo, amid the coronavirus disease (COVID-19) outbreak, during the traditional spring holiday of 'Shem al-Neseem', in Cairo, Egypt, May 3, 2021. REUTERS/Sayed Sheasha/File Photo
TT

Egypt’s Senate Approves Sovereign Sukuk Law

A general view of empty streets in downtown Cairo, amid the coronavirus disease (COVID-19) outbreak, during the traditional spring holiday of 'Shem al-Neseem', in Cairo, Egypt, May 3, 2021. REUTERS/Sayed Sheasha/File Photo
A general view of empty streets in downtown Cairo, amid the coronavirus disease (COVID-19) outbreak, during the traditional spring holiday of 'Shem al-Neseem', in Cairo, Egypt, May 3, 2021. REUTERS/Sayed Sheasha/File Photo

Egypt’s senate approved Monday a draft law submitted by the government regarding the issuance of a sovereign Sukuk.

Speaker Abdel Wahab Abdel Razek chaired a plenary session during which the senate discussed the draft law which aims to improves the state’s financial performance and cover the budget deficit.

Senators welcomed the bill, stating that it will help bring in unconventional investments and preserve the state’s right to ownership of assets and the rights of investors all while complying with Islamic law.

A report prepared by the Senate's economic and financial affairs committee said the 24-article bill comes through creating new tools for covering the budget deficit, diversifying sources of finance, and stimulating demand on government-issued financial securities.

The sovereign bonds are a new kind of government financial securities that go in line with Islamic Sharia and aim to attract Egyptian and foreign investors who abstain from investing in traditional financial and debt servicing securities currently on the market, according to the report.

Youssef Amer, chair of the Senate Religious and Endowments Affairs Committee, said that the new law guarantees the right of ownership to the state, in accordance with Islamic Sharia.

Amer explained that the law encourages state-protected investment, helps establish development projects, and maximizes the national economy.

Representative Ahmed Diab, a member of the Senate Youth and Sports Committee, affirmed that the sovereign Sukuk is in compliance with the Islamic Sharia as one of the highly accepted financing instruments and approved in global financial markets.

Diab explained that introducing sovereign Sukuk in Egypt will attract new national and foreign investors who do not invest in the current government instruments, especially since the state depends on other financing tools, such as bonds and treasury bills which resulted in increasing debts.

The draft law regulates the authorities concerned with issuing the Sukuk, including their form and characteristics, the issuance formulas, and their compatibility with the provisions of Islamic Sharia.

It also details the authentication process and its circulation, the application of taxes to the Sukuk, ownership rights, and the obligations of the beneficiary.

According to Article (13) of the law, the Sukuk has a maturity of 30 years, however, it is permissible to reconstruct the bonds after the end of their original period for similar periods.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.